Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
M. Manning(University of Toledo Medical Center), Gilles Guillon(Centre National de la Recherche Scientifique), Aleksandra Misicka(University of Warsaw), S. Stoev(Trakia University), Maïthé Corbani(Centre National de la Recherche Scientifique), Thierry Durroux(Centre National de la Recherche Scientifique), Aleksandra Olma(University of Łódź), K. Bańkowski(Instytut Farmaceutyczny), Bice Chini(Neuroscience Institute), Bernard Mouillac(Centre National de la Recherche Scientifique)
Cited by 424
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
A New Population of Parvocellular Oxytocin Neurons Controlling Magnocellular Neuron Activity and Inflammatory Pain Processing
|Neuron|2016|395
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism
|Biological Psychiatry|2011|376
G-protein coupled receptors in lipid rafts and caveolae: how, when and why do they go there?
|Journal of Molecular Endocrinology|2004|360